50
Participants
Start Date
April 30, 2014
Primary Completion Date
November 12, 2019
Study Completion Date
November 12, 2019
Intravitreal aflibercept injection
Intravitreal aflibercept injection 2 mg (0.05 mL) administered every 4 weeks for the first 3 months, followed by 2 mg (0.05 mL) intravitreal injection once every 8 weeks(2 months) with the option to treat monthly based on retreatment criteria for a total duration of 12 months.
Shiley Eye Center, La Jolla
Regeneron Pharmaceuticals
INDUSTRY
University of California, San Diego
OTHER